NiveshIQ
Procter & Gamble Health Ltd.
NiveshIQ has detected 5 active signals on PGHL. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeAbout Procter & Gamble Health Ltd.
Procter & Gamble Health Limited (PGHL) is a leading Indian pharmaceutical and chemical manufacturer, operating as a subsidiary of Procter & Gamble Overseas India B.V. The company’s core business focuses on over-the-counter medicines, vitamins, minerals, and dietary supplements, with flagship brands such as Betamil, Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. In FY2023, PGHL generated revenue of ₹1,433 crore and net income of ₹357 crore, reflecting a healthy profit margin of 24.9%. Recent developments include a strategic rebranding from Merck Limited to PGHL in 2019, which has strengthened its global brand equity and expanded its distribution network across India and abroad. Competitively, PGHL benefits from strong R&D capabilities, a diversified product portfolio
Financial Highlights
| Metric | FY26 |
|---|---|
| Revenue | ₹1,385 Cr +22.60% |
| EBITDA Margin | 34.22% |
| Net Profit | ₹326.91 Cr +62.70% |
| EPS | ₹197.00 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Strategic Outlook
- Q1FY27 results: revenue ₹364 Cr, PAT ₹96 Cr, EPS ₹57.92, EBITDA margin 37.2%. Growth context: revenue YoY +7.4%, PAT YoY +45.3%, revenue QoQ -1.8%, PAT QoQ +1.6%.
Product pipeline delivery, domestic demand, export mix, approvals, and margin discipline remain the key forward drivers ...
FY26 (last completed FY): revenue ₹1, 385 Cr, PAT ₹327 Cr, EBITDA margin 34.2%, EPS ₹197.00. Year-on-year: revenue YoY +...
Everything you unlock with a free account
Frequently Asked Questions
What AI signals does NiveshIQ provide for Procter & Gamble Health Ltd.?
NiveshIQ detects active intelligence signals for Procter & Gamble Health Ltd. (PGHL) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Procter & Gamble Health Ltd.?
Procter & Gamble Health Ltd. operates in the Healthcare sector with a market capitalisation of ₹889,726.9L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.